Meglumine antimoniate

DB13732InvestigationalSmall molecule

Meglumine antimoniate: Overview.

Chemical structure of Meglumine antimoniate
Formula / weight
C7H18NO8Sb · 365.98 g/mol (avg)
Also known as
Glucantim · Glucantime · Meglumine antimonate

Resolves to

Compound
UNII75G4TW236WCAS133-51-7ChEMBLCHEMBL239129
Clinical / RWD
RxNorm319866ATCP01CB01
Structure
InChIKeyXOGYVDXPYVPAAQ-SESJOKTNSA-MSMILESO[Sb](=O)=O.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

What you can answer from here — as of March 06, 2025

25Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Marketed productsAcross 2 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in

Which companies are running trials of Meglumine antimoniate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In